The association between asthma and rhinitis is stable over time despite diverging trends in prevalence.

Related Articles

The association between asthma and rhinitis is stable over time despite diverging trends in prevalence.

Respir Med. 2015 Jan 21;

Authors: Bjerg A, Eriksson J, Ólafsdóttir IS, Middelveld R, Franklin K, Forsberg B, Larsson K, Torén K, Dahlén SE, Janson C

Abstract
BACKGROUND: Despite the well-known association between asthma and rhinitis, in Swedish adults the prevalence of rhinitis rose from 22% to 31% between 1990 and 2008 while asthma prevalence was unchanged. We tested whether the association of rhinitis with asthma was stable over time using the same population-based databases.
METHODS: Two surveys of adults (20-44 years) living in three regions of Sweden, carried out in 1990 (n = 8982) and 2008 (n = 9156) were compared. Identical questions regarding respiratory symptoms, asthma and rhinitis were used. Asthmatic wheeze: Wheeze with breathlessness apart from colds. Current asthma: Asthma attacks and/or asthma medication use.
RESULTS: Subjects with rhinitis had level time trends in asthmatic wheeze, current asthma and most nocturnal respiratory symptoms between 1990 and 2008, adjusted for age, sex, area and smoking. Any wheeze however decreased slightly. In never-smokers asthma symptoms were similarly associated with rhinitis in 1990 and 2008: any wheeze OR 4.0 vs. 4.4 (p = 0.339); asthmatic wheeze OR 6.0 vs. 5.9 (p = 0.937); and current asthma OR 9.6 vs. 7.7 (p = 0.213). In the whole population there were decreases in the asthma symptoms most closely associated to smoking, which decreased by half 1990-2008. Conversely current asthma, which was strongly associated with rhinitis and not with smoking, increased (p < 0.001).
CONCLUSIONS: The association of rhinitis with asthma was stable between 1990 and 2008. The pattern in the time trends of asthma outcomes strongly suggests that decreased smoking counterbalanced the driving effect of increased rhinitis on asthma prevalence. The findings illustrate the public health benefits of decreased smoking.

PMID: 25638411 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Report: Asthma market to remain stable during next decade – Healio

Report: Asthma market to remain stable during next decade
Healio
The asthma market is projected to remain stable in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan with a slight increase from $15.1 billion in 2013 to $16.1 billion in 2023, according to a report from Decision Resources
Asthma market to remain stable over next decade, despite generic erosionThe Pharma Letter

all 2 news articles »

View full post on asthma – Google News

Asthma market to remain stable over next decade, despite generic erosion – The Pharma Letter


The Pharma Letter

Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter
New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic …

View full post on asthma – Google News

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite … – The Providence Journal

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite
The Providence Journal
BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain

and more »

View full post on asthma – Google News

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite … – MarketWatch

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite
MarketWatch
BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain

View full post on asthma – Google News